Driving with diabetes in the future: in-vehicle medical monitoring.
Kerr
David
D
Centre of Postgraduate Medical Research and Education, Bournemouth University, Bournemouth, United Kingdom. david.kerr@rbch.nhs.uk
Olateju
Tolulope
T
D000063:Accidents, Traffic / Q000517:prevention & control; D001334:Automobile Driving / Q000592:standards*; D001364:Awareness; D003072:Cognition Disorders / Q000503:physiopathology; D048909:Diabetes Complications / Q000503:physiopathology; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology*; D003925:Diabetic Angiopathies / Q000503:physiopathology; D003930:Diabetic Retinopathy / Q000503:physiopathology; D004827:Epilepsy / Q000503:physiopathology; D006801:Humans; D007003:Hypoglycemia / Q000453:epidemiology / Q000503:physiopathology; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D007328:Insulin / Q000009:adverse effects / Q000627:therapeutic use; D008004:Licensure / Q000331:legislation & jurisprudence; D008991:Monitoring, Physiologic / Q000379:methods*; D009203:Myocardial Infarction / Q000503:physiopathology; D009765:Obesity / Q000503:physiopathology; D012449:Safety; D020521:Stroke / Q000503:physiopathology; D014481:United States
D007004:Hypoglycemic Agents; D007328:Insulin